Page last updated: 2024-08-24

plerixafor and Diabetic Nephropathies

plerixafor has been researched along with Diabetic Nephropathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Advani, A; Advani, SL; Alghamdi, TA; Batchu, SN; Chen, LH; Connelly, KA; Gibson, IW; Marsden, PA; Siddiqi, FS; Sood, MM; Thai, K; White, KE1
Drucker, DJ; Fujishima, H; Fujita, H; Morii, T; Narita, T; Sato, T; Seino, Y; Shimizu, T; Takahashi, T; Takashima, S; Tsukiyama, K; Yamada, Y1

Other Studies

2 other study(ies) available for plerixafor and Diabetic Nephropathies

ArticleYear
CXCR4 promotes renal tubular cell survival in male diabetic rats: implications for ligand inactivation in the human kidney.
    Endocrinology, 2015, Volume: 156, Issue:3

    Topics: Albuminuria; Animals; Benzylamines; Cell Survival; Chemokine CXCL12; Cyclams; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Gene Expression Regulation; Heterocyclic Compounds; Humans; Kidney Tubules; Male; Matrix Metalloproteinase 9; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Real-Time Polymerase Chain Reaction; Receptors, CXCR; Receptors, CXCR4

2015
Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy.
    Kidney international, 2016, Volume: 90, Issue:4

    Topics: Albuminuria; Animals; Benzylamines; Chemokine CXCL12; Cyclams; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Female; Fibrosis; Glomerular Filtration Rate; Glucagon-Like Peptide-1 Receptor; Heterocyclic Compounds; Humans; Hypoglycemic Agents; Kidney; Linagliptin; Liraglutide; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Receptors, CXCR4; Up-Regulation

2016